News

This Time Must Be Different: Disparities During the COVID-19 Pandemic

This note was first published with references in the Annals of Internal Medicine.

Katie Pollard Named 2020 ISCB Fellow

The International Society for Computational Biology (ISCB) has named Katie Pollard, PhD, a 2020 ISCB Fellow. She was selected for being a “world leader in developing statistical models and open-source bioinformatics software for biological big data, with an emphasis on genomics.” Pollard was one of...

Science during a crisis: Faculty look to clinical trials to find drugs that combat Covid-19

Much of the news coverage of the COVID-19 epidemic has pointed to the promise of the anti-malarial drug hydroxychloroquine to combat the novel coronavirus that causes COVID-19. Hydroxychloroquine is one of three drugs that researchers have flagged as possible treatments for COVID-19.

Coronavirus Survivors Hope for Immunity — The Reality Is More Complicated

This article first appeared on Bloomberg.com As the number of new Covid-19 cases each day begins to slow in parts of the U.S. and states consider rolling back social-distancing measures, a huge unknown remains: Who has become immune to the disease — and for how long?

UCSF launches dashboard to track how social determinants affect population health

This article was first published in Becker's Hospital Review.

To aid coronavirus fight, The Times releases database of California cases

This article was first published in the LA Times

To understand a new disease, start at the beginning

Would you know if you had COVID-19?  

New COVID-19 ‘Citizen Science’ Initiative Lets Any Adult with a Smartphone Help to Fight Coronavirus

To help fight the novel coronavirus now plaguing humanity, a new initiative by UC San Francisco physician-scientists, dubbed COVID-19 Citizen Science (CSS), will allow anyone in the world age 18 or over to become a citizen scientist advancing understanding of the disease.

Where are we on the curve of this epidemic?

When the City of San Francisco effectively grounded its residents on March 16, there were just 23 confirmed local cases. It was hard not to wonder if the restrictions were really necessary.

Treatment to new lower blood pressure treatment targets not supported by evidence for people under 50 or over 70

Underrepresentation in clinical trials leaves evidence gaps for younger adults with low cardiovascular risk and in older adults with multiple health conditions, study finds